Tokyo Tape
Sign in
← Muromachi Chemicals

Annual report

4885.TEDINET S100WL9D
Period2024-06-01 → 2025-05-31
Filed2025-08-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 93
MetricValuePeriodScopeSource row
Revenue¥6.7bn2024-06-01 → 2025-05-31StandaloneNet sales
Revenue¥6.4bn2023-06-01 → 2024-05-31StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31vStandaloneNet sales (5-year summary)
Revenue¥5.7bn2021-06-01 → 2022-05-31vStandaloneNet sales (5-year summary)
Revenue¥4.9bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Operating income¥432m2024-06-01 → 2025-05-31StandaloneOperating income
Operating income¥422m2023-06-01 → 2024-05-31StandaloneOperating income
Ordinary income¥430m2024-06-01 → 2025-05-31StandaloneOrdinary income
Ordinary income¥428m2023-06-01 → 2024-05-31StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥423m2021-06-01 → 2022-05-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥339m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥350m2024-06-01 → 2025-05-31StandaloneIncome before income taxes
Profit before tax¥469m2023-06-01 → 2024-05-31StandaloneIncome before income taxes
Net income¥241m2024-06-01 → 2025-05-31StandaloneProfit loss
Net income¥330m2023-06-01 → 2024-05-31StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31vStandaloneNet income loss (5-year summary)
Net income¥456m2021-06-01 → 2022-05-31vStandaloneNet income loss (5-year summary)
Net income¥181m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.3bnat 2025-05-31StandaloneAssets
Total assets¥5.1bnat 2024-05-31StandaloneAssets
Total assets¥4.9bnat 2023-05-31vStandaloneTotal assets (5-year summary)
Total assets¥4.8bnat 2022-05-31vStandaloneTotal assets (5-year summary)
Total assets¥4.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥2.8bnat 2025-05-31StandaloneLiabilities
Total liabilities¥2.8bnat 2024-05-31StandaloneLiabilities
Net assets / equity¥2.5bnat 2025-05-31StandaloneNet assets
Net assets / equity¥2.3bnat 2024-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31vStandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31vStandaloneNet assets (5-year summary)
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2025-05-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-05-31StandaloneCash and deposits
Cash & equivalents¥1.0bnat 2025-05-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-05-31StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31vStandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥216m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥638m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥525m2021-06-01 → 2022-05-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥488m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥371m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥232m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥176m2021-06-01 → 2022-05-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥58m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥123m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥210m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥484m2021-06-01 → 2022-05-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥311m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥60.422024-06-01 → 2025-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.422023-06-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥65.242020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥59.492024-06-01 → 2025-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥81.862023-06-01 → 2024-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥56.972020-06-01 → 2021-05-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥252024-06-01 → 2025-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥222023-06-01 → 2024-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥152020-06-01 → 2021-05-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥612.4at 2025-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥571.26at 2024-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥487.25at 2023-05-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥450.37at 2022-05-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥363.93at 2021-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio46.6%at 2025-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.9%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.9%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE10.2%2024-06-01 → 2025-05-31StandaloneRate of return on equity (5-year summary)
ROE15.8%2023-06-01 → 2024-05-31StandaloneRate of return on equity (5-year summary)
ROE14.3%2022-06-01 → 2023-05-31vStandaloneRate of return on equity (5-year summary)
ROE30.3%2021-06-01 → 2022-05-31vStandaloneRate of return on equity (5-year summary)
ROE22.8%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,095,500at 2025-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees203at 2025-05-31StandaloneNumber of employees
Employees205at 2024-05-31StandaloneNumber of employees
Employees205at 2023-05-31vStandaloneNumber of employees
Employees197at 2022-05-31vStandaloneNumber of employees
Employees195at 2021-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2025-05-31¥1.7bn
Chemical Products Businessreportable segmentcapex2024-06-01 → 2025-05-31¥78m
Chemical Products Businessreportable segmentdepreciation2024-06-01 → 2025-05-31¥61m
Chemical Products Businessreportable segmentemployeesat 2025-05-3152 pure
Chemical Products Businessreportable segmentrevenue2024-06-01 → 2025-05-31¥2.4bn
Chemical Products Businessreportable segmentrevenue external2024-06-01 → 2025-05-31¥2.4bn
Chemical Products Businessreportable segmentsegment assetsat 2025-05-31¥1.1bn
Chemical Products Businessreportable segmentsegment profit2024-06-01 → 2025-05-31¥57m
Healthy Food Businessreportable segmentcapex2024-06-01 → 2025-05-31¥33m
Healthy Food Businessreportable segmentdepreciation2024-06-01 → 2025-05-31¥28m
Healthy Food Businessreportable segmentemployeesat 2025-05-3121 pure
Healthy Food Businessreportable segmentrevenue2024-06-01 → 2025-05-31¥1.0bn
Healthy Food Businessreportable segmentrevenue external2024-06-01 → 2025-05-31¥1.0bn
Healthy Food Businessreportable segmentsegment assetsat 2025-05-31¥334m
Healthy Food Businessreportable segmentsegment profit2024-06-01 → 2025-05-31−¥99m
Pharmaceutical Businessreportable segmentcapex2024-06-01 → 2025-05-31¥182m
Pharmaceutical Businessreportable segmentdepreciation2024-06-01 → 2025-05-31¥74m
Pharmaceutical Businessreportable segmentemployeesat 2025-05-3155 pure
Pharmaceutical Businessreportable segmentrevenue2024-06-01 → 2025-05-31¥3.2bn
Pharmaceutical Businessreportable segmentrevenue external2024-06-01 → 2025-05-31¥3.2bn
Pharmaceutical Businessreportable segmentsegment assetsat 2025-05-31¥2.1bn
Pharmaceutical Businessreportable segmentsegment profit2024-06-01 → 2025-05-31¥474m
Total Of Reportable Segments And Otherssegment totalcapex2024-06-01 → 2025-05-31¥292m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-06-01 → 2025-05-31¥162m
Total Of Reportable Segments And Otherssegment totalrevenue2024-06-01 → 2025-05-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-06-01 → 2025-05-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2025-05-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-06-01 → 2025-05-31¥432m
Reconciling Itemsreconcilingsegment assetsat 2024-05-31¥1.6bn
Chemical Products Businessreportable segmentcapex2023-06-01 → 2024-05-31¥77m
Chemical Products Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥56m
Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentsegment assetsat 2024-05-31¥1.1bn
Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥16m
Healthy Food Businessreportable segmentcapex2023-06-01 → 2024-05-31¥15m
Healthy Food Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥27m
Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentsegment assetsat 2024-05-31¥473m
Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥38m
Pharmaceutical Businessreportable segmentcapex2023-06-01 → 2024-05-31¥198m
Pharmaceutical Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥54m
Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentsegment assetsat 2024-05-31¥1.9bn
Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-05-31¥476m
Total Of Reportable Segments And Otherssegment totalcapex2023-06-01 → 2024-05-31¥289m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-06-01 → 2024-05-31¥136m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-05-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-05-31¥422m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,236
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)寺　　田　　篤　　芳
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)宮　　嵜　　　 健
Key audit matters non consolidated (text)FilingDateInstantText · Plus
Overview kam non consolidated (text)FilingDateInstantText · Plus
Short description kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)固定資産に関する減損会計の適用
Description including reason kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Reference kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)重要な会計上の見積り
Auditors response kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Other information non consolidated (text)FilingDateInstantText · Plus
Fee related information non consolidated (text)FilingDateInstantText · Plus
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior4YearDuration_NonConsolidatedMember4942963000JPY
Net sales (5-year summary)Prior3YearDuration_NonConsolidatedMember5681099000JPY
Net sales (5-year summary)Prior2YearDuration_NonConsolidatedMember6291379000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember6369097000JPY
Net sales (5-year summary)CurrentYearDuration_NonConsolidatedMember6653028000JPY
Ordinary income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember339322000JPY
Ordinary income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember423041000JPY
Ordinary income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember350890000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember428106000JPY
Ordinary income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember430093000JPY
Net income loss (5-year summary)Prior4YearDuration_NonConsolidatedMember180714000JPY
Net income loss (5-year summary)Prior3YearDuration_NonConsolidatedMember456272000JPY
Net income loss (5-year summary)Prior2YearDuration_NonConsolidatedMember256302000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember330197000JPY
Net income loss (5-year summary)CurrentYearDuration_NonConsolidatedMember241277000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior4YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior3YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior2YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember－JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYearDuration_NonConsolidatedMember－JPY
Capital stock (5-year summary)Prior4YearInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)Prior3YearInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)Prior2YearInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember143172000JPY
Capital stock (5-year summary)CurrentYearInstant_NonConsolidatedMember143172000JPY
Total number of issued shares (5-year summary)Prior4YearInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)Prior3YearInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)Prior2YearInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember4095500
Total number of issued shares (5-year summary)CurrentYearInstant_NonConsolidatedMember4095500
Net assets (5-year summary)Prior4YearInstant_NonConsolidatedMember1334001000JPY
Net assets (5-year summary)Prior3YearInstant_NonConsolidatedMember1681080000JPY
Net assets (5-year summary)Prior2YearInstant_NonConsolidatedMember1915229000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember2271221000JPY
Net assets (5-year summary)CurrentYearInstant_NonConsolidatedMember2451781000JPY
Total assets (5-year summary)Prior4YearInstant_NonConsolidatedMember4612324000JPY
Total assets (5-year summary)Prior3YearInstant_NonConsolidatedMember4798071000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-05-31pass
balance sheet identitynon_consolidated 2025-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · net assetsnon_consolidated 2025-05-31pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · operating cash flownon_consolidated 2024-06-01/2025-05-31pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · revenuenon_consolidated 2024-06-01/2025-05-31pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass
statement vs summary · total assetsnon_consolidated 2025-05-31pass